Semaglutide works by mimicking the GLP-1 hormone, which slows down your digestion making you feel fuller longer. Semaglutide reduces appetite and food cravings, leading to decreased calorie intake and sustainable weight loss.

Tirzepatide targets both GIP and GLP-1 hormones that regulate appetite and blood sugar levels, helping reduce hunger and promote a feeling of fullness, leading to significant weight loss.

Semaglutide:

• Appetite Suppression: Semaglutide slows gastric emptying, which helps reduce appetite and calorie intake.
• Blood Sugar Control: It enhances insulin secretion and inhibits glucagon release, which helps stabilize blood sugar levels.
• Weight Loss: By reducing hunger and promoting satiety, Semaglutide supports sustained weight loss.

Tirzepatide:

• Dual Action: Combines the effects of GLP-1 and GIP to enhance weight loss and improve metabolic health.
• Appetite Regulation: It reduces hunger and increases the feeling of fullness after meals.
• Metabolic Benefits: Improves insulin sensitivity and helps control blood sugar levels, which can contribute to weight reduction.

• Significant Weight Loss: Clinical trials have shown substantial weight loss in individuals using these medications.
• Improved Metabolic Health: Both medications help improve insulin sensitivity and control blood sugar levels.
• Appetite Control: They effectively reduce hunger and enhance satiety, making it easier to adhere to a healthy diet.
• Convenient Administration: These medications are administered via a simple injection, typically once a week.

While Semaglutide and Tirzepatide are generally well-tolerated, some individuals may experience side effects, including:

• Nausea and Vomiting: Common during the initial stages of treatment as the body adjusts.
• Diarrhea or Constipation: Gastrointestinal issues may occur but often subside over time.
• Injection Site Reactions: Mild discomfort or irritation at the injection site.
• Low Blood Sugar: Rare but possible, especially when combined with other diabetes medications.